Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PDC-lung by PDC Line Pharma for Non-Small Cell Lung Cancer: Likelihood of Approval
PDC-lung is under clinical development by PDC Line Pharma and currently in Phase II for Non-Small Cell Lung Cancer. According...